Skip to content

Public FDA record

Z-0702-05: Version 12 software program written for the Bio-Tek ELx800 automated microtiter plate reader with use of

Recall record Z-0702-05 for Diasorin Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0702-05
Company in FDA record
Diasorin Inc.
FDA classification date
Apr 13, 2005
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

The software program written for use in the automated microtiter plate reader (Bio-Tek ELx800) for use with the Pro-Trac II Tacrolimus ELISA kit was found to be faulty. Assay software program did not include the Calibrator Zero OD specification (STDO>=1.500) as specified in the product insert.

Source facts

Action
Customers were sent notification letters and effectiveness check form. recommended users manually veify results using product insert specifications.
Initiated
2004-04-12
Root cause
Other
Terminated
2006-07-22
Distribution
CA, Washington DC, FL, KY & Canada
Recall number
Z-0702-05
Recall status
Terminated
CDRH record ID
36821
FDA classified
2005-04-13
Recall event number
30929

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗